KIMBERLY DENT: Open Payments
NPI 1477988277 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 33 payments from 14 companies in 2025. Trend: 2023 $490 · 2024 $364 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Grifols USA, LLC | 1 | $36 |
| Inspire Medical Systems, Inc. | 1 | $35 |
| Philips North America LLC | 1 | $25 |
| Insmed, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: DUPIXENT, NUCALA, BREZTRI, Prolastin-C Liquid, INSPIRE, WINREVAIR, Vest Therapy Und, Arikayce.
Industry payments across MO — which companies pay providers there.
